RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
Cristina Cruz(Vall d'Hebron Institute of Oncology), Marta Castroviejo‐Bermejo, Sara Gutiérrez‐Enríquez, Alba Llop‐Guevara, Yasir H. Ibrahim, Albert Gris‐Oliver, Sandra Bonache, Beatriz Morancho(Vall d'Hebron Institute of Oncology), Alejandra Bruna(Cancer Research UK Cambridge Center), Oscar M. Rueda(Cancer Research UK Cambridge Center), Zhongwu Lai(AstraZeneca (United States)), Urszula M. Polanska(Cancer Research UK), Gemma N. Jones(Cancer Research UK), Petra Kristel(Cancer Genomics Centre), L.D. Bustos, Marta Guzmán, Olga Rodríguez, Judit Grueso, Gemma Montalban, Ginevra Caratù(Cancer Genomics Centre), Francesco M. Mancuso(Cancer Genomics Centre), Roberta Fasani(Molecular Oncology (United States)), José Jiménez(Vall d'Hebron Institute of Oncology), William Howat(AstraZeneca (United Kingdom)), Brian Dougherty(AstraZeneca (United States)), Ana Vivancos(Cancer Genomics Centre), Paolo Nucíforo(Molecular Oncology (United States)), Xavier Serres, Isabel T. Rubio(Universitat Autònoma de Barcelona), Ana Oaknin(Vall d'Hebron Institute of Oncology), Elaine Cadogan(AstraZeneca (United Kingdom)), J. Carl Barrett(AstraZeneca (United States)), Carlos Caldas(University of Cambridge), José Baselga(Memorial Sloan Kettering Cancer Center), Cristina Saura(Vall d'Hebron Institute of Oncology), Javier Cortés(Vall d'Hebron Institute of Oncology), Joaquı́n Arribas(Centro de Investigación Biomédica en Red de Cáncer), Jos Jonkers(Cancer Genomics Centre), Orland Dı́ez(Universitat Autònoma de Barcelona), Mark J. O’Connor(AstraZeneca (United Kingdom)), Judith Balmañà(Universitat Autònoma de Barcelona), Violeta Serra(Centro de Investigación Biomédica en Red de Cáncer)
Cited by 421Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis